Boryung Pharm wins Korea patent for novel antihypertensive formulation
According to the novel process patent, the novel antihypertensive compound (codename: BRA-657) has an antagonizing action again...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
